CLINICAL_TRIALS
trial_result
· 2015-08-13
Clinical Trial Update: A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) [Phase 1]
Summary
Completed Phase 1 study evaluating SP-02L in patients with relapsed or refractory Peripheral T-cell lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Solasia Pharma K.K. | Conditions: Peripheral T-cell Lymphoma | Phase 1 | Status: COMPLETED